One Bridget Dintwe, PhD
One Bridget Dintwe, PhD
Staff Scientist
Immunology and Vaccine Development, Fred Hutch
Research Officer
Cape Town HVTN Immunology Laboratory
Oversight for quality control of Good Clinical Lab Practice (GCLP)-compliant assays and is studying cellular immune responses to HIV vaccines for the Cape Town HVTN laboratory. Research involves interrogation of the phenotype and transcriptional profile of vaccine induced T cells in order to better understand these T cell responses.
Education
2005-2007 University of Cape Town BS (Biochemistry and Microbiology)
2008 University of Cape Town BS Honours (Microbiology)
2011-2014 University of Cape Town, South African TB Vaccine Initiative Ph.D. in Clinical Sciences and Immunology
Research Interests
At CHIL, One has local oversight for quality control of Good Clinical Lab Practice (GCLP)-compliant assays and is studying cellular immune responses to HIV vaccines. One is involved in the optimization and running of assays in support of HVTN trials. One is also involved in the training of staff at CHIL, and oversees a staff compliment of 6 technologist and one data coordinator. One is interested in understanding the role of vaccine induced memory T-cells, and which memory T cell subsets should a vaccine aim to induce for protection against HIV.
One’s research will involve thorough interrogation of the phenotype and transcriptional profile of vaccine induced T cells in order to better understand these T cell responses.
Dr. Dintwe is a member of the Cape Town HVTN Immunology Laboratory.